↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$633KSold on the market
1Companies
Aug 19, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 202616:05 | Aug 18, 2026from Aug 17, 2026 | TVTXTravere Therapeutics, Inc. | Director | S · Sell10b5-1 | $63.28 | −10,000 | 61,500 | -14% | −$633K | ||
| Aug 19, 202616:05 | Aug 18, 2026from Aug 17, 2026 | TVTXTravere Therapeutics, Inc. | Director | M · Exercise10b5-1 | $17.44 | +10,000 | 66,500 | +18% | $174K |